Premium
Tests for bioequivalence of control media and test media in studies of toxicity
Author(s) -
Erickson Wallace P.,
McDonald Lyman L.
Publication year - 1995
Publication title -
environmental toxicology and chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.1
H-Index - 171
eISSN - 1552-8618
pISSN - 0730-7268
DOI - 10.1002/etc.5620140718
Subject(s) - bioequivalence , null hypothesis , statistical hypothesis testing , replication (statistics) , test (biology) , econometrics , statistical power , statistics , alternative hypothesis , control (management) , type i and type ii errors , toxicology , psychology , computer science , mathematics , medicine , biology , pharmacology , artificial intelligence , pharmacokinetics , paleontology
Abstract Statistical tests of the classical (null) hypothesis–that there is no difference in effects of control media and test media– are commonly used to make statistical inferences toward the no‐observed‐adverse‐effect concentration. However, failing to reject this hypothesis is not considered as scientific proof the hypothesis is true. An effect may exist, but high variation due to inadequate replication, variation in experimental units, or imprecise measurement techniques may yield data for which the hypothesis is not rejected. An experiment may also be too precise, yielding effects that are statistically significant but not biologically important. We propose the use of tests of bioequivalence of control media and test media to alleviate these unsatisfactory characteristics of tests of the classical hypotheses for regulatory decisions. We review and illustrate the test for bioequivalence using acute and chronic toxicity data. We also define a procedure for determining the level of effect at which there will be high power to refute the hypothesis that there is a lack of bioequivalence if in fact the biological response in the control media is identical to the response in the test media.